Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.7772 |
Intermediate Similarity |
NPD5684 |
Clinical (unspecified phase) |
0.7772 |
Intermediate Similarity |
NPD5682 |
Phase 3 |
0.7772 |
Intermediate Similarity |
NPD5683 |
Clinical (unspecified phase) |
0.7377 |
Intermediate Similarity |
NPD3107 |
Discontinued |
0.7287 |
Intermediate Similarity |
NPD3083 |
Approved |
0.7258 |
Intermediate Similarity |
NPD2646 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD249 |
Approved |
0.7222 |
Intermediate Similarity |
NPD250 |
Approved |
0.7173 |
Intermediate Similarity |
NPD1776 |
Approved |
0.7173 |
Intermediate Similarity |
NPD1777 |
Approved |
0.7143 |
Intermediate Similarity |
NPD186 |
Discovery |
0.7143 |
Intermediate Similarity |
NPD195 |
Approved |
0.7128 |
Intermediate Similarity |
NPD5666 |
Phase 2 |
0.7114 |
Intermediate Similarity |
NPD7138 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD7988 |
Suspended |
0.7074 |
Intermediate Similarity |
NPD2624 |
Phase 2 |
0.7071 |
Intermediate Similarity |
NPD4716 |
Approved |
0.7059 |
Intermediate Similarity |
NPD339 |
Approved |
0.7047 |
Intermediate Similarity |
NPD2647 |
Phase 3 |
0.7035 |
Intermediate Similarity |
NPD4744 |
Clinical (unspecified phase) |
0.7021 |
Intermediate Similarity |
NPD169 |
Phase 2 |
0.7005 |
Intermediate Similarity |
NPD1750 |
Clinical (unspecified phase) |
0.7005 |
Intermediate Similarity |
NPD338 |
Approved |
0.7005 |
Intermediate Similarity |
NPD1369 |
Phase 2 |
0.6989 |
Remote Similarity |
NPD283 |
Approved |
0.6923 |
Remote Similarity |
NPD185 |
Approved |
0.6915 |
Remote Similarity |
NPD242 |
Approved |
0.6897 |
Remote Similarity |
NPD6417 |
Clinical (unspecified phase) |
0.6895 |
Remote Similarity |
NPD1732 |
Phase 3 |
0.6882 |
Remote Similarity |
NPD548 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD516 |
Clinical (unspecified phase) |
0.6848 |
Remote Similarity |
NPD166 |
Approved |
0.6813 |
Remote Similarity |
NPD193 |
Suspended |
0.6803 |
Remote Similarity |
NPD6023 |
Discontinued |
0.6755 |
Remote Similarity |
NPD3708 |
Phase 2 |
0.675 |
Remote Similarity |
NPD4171 |
Clinical (unspecified phase) |
0.6719 |
Remote Similarity |
NPD219 |
Phase 3 |
0.6719 |
Remote Similarity |
NPD218 |
Approved |
0.6719 |
Remote Similarity |
NPD220 |
Clinical (unspecified phase) |
0.6719 |
Remote Similarity |
NPD216 |
Approved |
0.6719 |
Remote Similarity |
NPD217 |
Approved |
0.6716 |
Remote Similarity |
NPD1692 |
Approved |
0.6695 |
Remote Similarity |
NPD8375 |
Approved |
0.6695 |
Remote Similarity |
NPD8291 |
Clinical (unspecified phase) |
0.6639 |
Remote Similarity |
NPD8371 |
Clinical (unspecified phase) |
0.6632 |
Remote Similarity |
NPD546 |
Clinical (unspecified phase) |
0.662 |
Remote Similarity |
NPD2965 |
Clinical (unspecified phase) |
0.6592 |
Remote Similarity |
NPD5080 |
Phase 2 |
0.6578 |
Remote Similarity |
NPD7158 |
Phase 1 |
0.6566 |
Remote Similarity |
NPD247 |
Clinical (unspecified phase) |
0.6562 |
Remote Similarity |
NPD214 |
Approved |
0.6562 |
Remote Similarity |
NPD213 |
Clinical (unspecified phase) |
0.6552 |
Remote Similarity |
NPD1412 |
Clinical (unspecified phase) |
0.6547 |
Remote Similarity |
NPD5079 |
Phase 2 |
0.6514 |
Remote Similarity |
NPD2877 |
Clinical (unspecified phase) |
0.6514 |
Remote Similarity |
NPD2876 |
Phase 3 |
0.6486 |
Remote Similarity |
NPD2902 |
Phase 2 |
0.6486 |
Remote Similarity |
NPD2903 |
Clinical (unspecified phase) |
0.6455 |
Remote Similarity |
NPD2824 |
Phase 2 |
0.6409 |
Remote Similarity |
NPD248 |
Discontinued |
0.6398 |
Remote Similarity |
NPD4054 |
Clinical (unspecified phase) |
0.6364 |
Remote Similarity |
NPD7323 |
Phase 2 |
0.6351 |
Remote Similarity |
NPD2630 |
Approved |
0.6351 |
Remote Similarity |
NPD2631 |
Clinical (unspecified phase) |
0.6351 |
Remote Similarity |
NPD2632 |
Approved |
0.6349 |
Remote Similarity |
NPD4240 |
Approved |
0.6329 |
Remote Similarity |
NPD8409 |
Suspended |
0.6316 |
Remote Similarity |
NPD171 |
Discontinued |
0.6313 |
Remote Similarity |
NPD5665 |
Clinical (unspecified phase) |
0.6289 |
Remote Similarity |
NPD7842 |
Phase 2 |
0.6277 |
Remote Similarity |
NPD549 |
Approved |
0.6277 |
Remote Similarity |
NPD3696 |
Approved |
0.6277 |
Remote Similarity |
NPD3695 |
Approved |
0.623 |
Remote Similarity |
NPD9632 |
Phase 3 |
0.615 |
Remote Similarity |
NPD252 |
Clinical (unspecified phase) |
0.612 |
Remote Similarity |
NPD870 |
Clinical (unspecified phase) |
0.6109 |
Remote Similarity |
NPD6840 |
Approved |
0.6091 |
Remote Similarity |
NPD536 |
Clinical (unspecified phase) |
0.608 |
Remote Similarity |
NPD8373 |
Clinical (unspecified phase) |
0.6048 |
Remote Similarity |
NPD1046 |
Clinical (unspecified phase) |
0.602 |
Remote Similarity |
NPD4074 |
Clinical (unspecified phase) |
0.6 |
Remote Similarity |
NPD7531 |
Clinical (unspecified phase) |
0.6 |
Remote Similarity |
NPD9633 |
Phase 3 |
0.5992 |
Remote Similarity |
NPD8250 |
Phase 2 |
0.599 |
Remote Similarity |
NPD1430 |
Approved |
0.599 |
Remote Similarity |
NPD3085 |
Phase 1 |
0.599 |
Remote Similarity |
NPD1431 |
Approved |
0.5966 |
Remote Similarity |
NPD4555 |
Clinical (unspecified phase) |
0.5965 |
Remote Similarity |
NPD4495 |
Phase 1 |
0.596 |
Remote Similarity |
NPD3086 |
Phase 3 |
0.5944 |
Remote Similarity |
NPD7850 |
Discontinued |
0.5944 |
Remote Similarity |
NPD7851 |
Phase 1 |
0.5939 |
Remote Similarity |
NPD6763 |
Discontinued |
0.5938 |
Remote Similarity |
NPD5486 |
Discontinued |
0.593 |
Remote Similarity |
NPD9605 |
Phase 3 |
0.5926 |
Remote Similarity |
NPD194 |
Clinical (unspecified phase) |
0.5899 |
Remote Similarity |
NPD2152 |
Clinical (unspecified phase) |
0.5893 |
Remote Similarity |
NPD4458 |
Phase 2 |
0.5893 |
Remote Similarity |
NPD4459 |
Clinical (unspecified phase) |
0.588 |
Remote Similarity |
NPD1063 |
Phase 2 |
0.5876 |
Remote Similarity |
NPD582 |
Approved |
0.5859 |
Remote Similarity |
NPD5458 |
Discontinued |
0.584 |
Remote Similarity |
NPD4896 |
Clinical (unspecified phase) |
0.5838 |
Remote Similarity |
NPD9408 |
Phase 3 |
0.5833 |
Remote Similarity |
NPD1808 |
Phase 1 |
0.5826 |
Remote Similarity |
NPD5072 |
Discontinued |
0.5787 |
Remote Similarity |
NPD1730 |
Discontinued |
0.5781 |
Remote Similarity |
NPD6381 |
Phase 2 |
0.5771 |
Remote Similarity |
NPD34 |
Approved |
0.5771 |
Remote Similarity |
NPD4714 |
Approved |
0.5771 |
Remote Similarity |
NPD231 |
Clinical (unspecified phase) |
0.5771 |
Remote Similarity |
NPD4713 |
Clinical (unspecified phase) |
0.5771 |
Remote Similarity |
NPD4715 |
Clinical (unspecified phase) |
0.5768 |
Remote Similarity |
NPD1571 |
Phase 2 |
0.5756 |
Remote Similarity |
NPD6036 |
Suspended |
0.5755 |
Remote Similarity |
NPD8421 |
Discontinued |
0.5729 |
Remote Similarity |
NPD1121 |
Approved |
0.5729 |
Remote Similarity |
NPD1120 |
Approved |
0.5714 |
Remote Similarity |
NPD6351 |
Discovery |
0.5714 |
Remote Similarity |
NPD7502 |
Clinical (unspecified phase) |
0.57 |
Remote Similarity |
NPD2593 |
Clinical (unspecified phase) |
0.5697 |
Remote Similarity |
NPD1572 |
Phase 2 |
0.5697 |
Remote Similarity |
NPD7486 |
Phase 1 |
0.5696 |
Remote Similarity |
NPD2453 |
Phase 2 |
0.5696 |
Remote Similarity |
NPD2451 |
Phase 2 |
0.5696 |
Remote Similarity |
NPD2452 |
Phase 2 |
0.5696 |
Remote Similarity |
NPD2450 |
Phase 2 |
0.5685 |
Remote Similarity |
NPD5887 |
Clinical (unspecified phase) |
0.568 |
Remote Similarity |
NPD5321 |
Phase 3 |
0.5678 |
Remote Similarity |
NPD8271 |
Discontinued |
0.5676 |
Remote Similarity |
NPD4950 |
Approved |
0.5663 |
Remote Similarity |
NPD2253 |
Discontinued |
0.5657 |
Remote Similarity |
NPD7197 |
Approved |
0.565 |
Remote Similarity |
NPD8329 |
Phase 3 |
0.5644 |
Remote Similarity |
NPD353 |
Discontinued |
0.5633 |
Remote Similarity |
NPD8119 |
Discontinued |
0.5625 |
Remote Similarity |
NPD8370 |
Discontinued |
0.5612 |
Remote Similarity |
NPD8327 |
Clinical (unspecified phase) |
0.5612 |
Remote Similarity |
NPD8326 |
Phase 3 |
0.5612 |
Remote Similarity |
NPD8325 |
Phase 3 |
0.5609 |
Remote Similarity |
NPD7103 |
Approved |
0.5607 |
Remote Similarity |
NPD3590 |
Clinical (unspecified phase) |
0.5607 |
Remote Similarity |
NPD5827 |
Discontinued |
0.5602
|
Remote Similarity |
NPD282 |
Approved |